Notably, although limited by sample size ( p = 0.0614), a strong trend towards reduced mortality (10% versus 40% in controls) was observed, suggesting a potential survival benefit.
← all excerpts
Growth Hormone-Releasing Peptide-6 (GHRP-6) Ameliorates Post-Infarct Ventricular Remodeling and Systolic Dysfunction in a Model of Permanent Coronary Ligation.
2
—
—
The sentences
Post-infarct myocardial interstitial fibrosis measurements using collagen-specific staining indicate that GHRP-6 intervention reduced tissue injury and the consequent scarring, although these differences did not reach statistical significance ( Figure 5 E).